Publications by authors named "John B Davis"

44 Publications

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.

Immunology 2021 Jan 30;162(1):84-91. Epub 2020 Oct 30.

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

View Article and Find Full Text PDF
January 2021

TargetDB: A target information aggregation tool and tractability predictor.

PLoS One 2020 2;15(9):e0232644. Epub 2020 Sep 2.

Nuffield Department of Medicine, ARUK Oxford Drug Discovery Institute, Target Discovery Institute, University of Oxford, Oxford, United-Kingdom.

View Article and Find Full Text PDF
October 2020

A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6.

J Pharmacol Toxicol Methods 2019 Jan - Feb;95:47-55. Epub 2018 Nov 23.

Alzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford, NDM Research Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7FZ, UK. Electronic address:

View Article and Find Full Text PDF
March 2019

Person-centered health care: capabilities and identity.

Authors:
John B Davis

Am J Bioeth 2013 ;13(8):61-2

Department of Economics, Marquette University, Milwaukee, WI 53201-1881,USA.

View Article and Find Full Text PDF
November 2013

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease.

Free Radic Biol Med 2011 Mar 23;50(5):633-40. Epub 2010 Dec 23.

Parkinson's Disease Research Group, Centre for Neuroscience, Division of Experimental Medicine, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.

View Article and Find Full Text PDF
March 2011

Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cells.

Life Sci 2011 Jan 4;88(3-4):141-9. Epub 2010 Nov 4.

Anaesthetics, Pain Medicine and Intensive Care Section, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, 369, Fulham Road, London, SW10 9NH, United Kingdom.

View Article and Find Full Text PDF
January 2011

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

J Neurochem 2009 Aug 22;110(3):966-75. Epub 2009 Jun 22.

Parkinson's Disease Research Group, Department of Cellular and Molecular Neuroscience, Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College London, London, UK.

View Article and Find Full Text PDF
August 2009

Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice.

Exp Neurol 2009 Apr;216(2):459-70

Neuroscience Centre of Excellence for Drug Discovery, GlaxoSmithKline, Third Avenue, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
April 2009

Perspectives of Alzheimer's disease treatments.

Handb Clin Neurol 2008 ;89:273-90

Neurology and GI CEDD, GlaxoSmithKline R&D Ltd, Harlow, UK.

View Article and Find Full Text PDF
December 2010

The individual in mainstream health economics: a case of Persona Non-grata.

Health Care Anal 2007 Sep 5;15(3):195-210. Epub 2007 Apr 5.

University of Amsterdam and Marquette University, Milwaukee, Wisconsin, USA,

View Article and Find Full Text PDF
September 2007

P2X(7) receptors on microglial cells mediate injury to cortical neurons in vitro.

Glia 2006 Aug;54(3):234-42

Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, New Frontiers Science Park, Third Avenue, Harlow CM19 5AW, Essex, United Kingdom.

View Article and Find Full Text PDF
August 2006

N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1.

Bioorg Med Chem Lett 2006 Sep 27;16(17):4533-6. Epub 2006 Jun 27.

Neurology and GI Center of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, UK.

View Article and Find Full Text PDF
September 2006

Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain.

J Orofac Pain 2005 ;19(3):248-60

School of Clinical Dentistry, University of Sheffield, Sheffield, South Yorkshire S10 2TA, United Kingdom.

View Article and Find Full Text PDF
November 2005

Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain.

BMC Womens Health 2005 Mar 8;5(1). Epub 2005 Mar 8.

Peripheral Neuropathy Unit, Hammersmith Hospital, Faculty of Medicine, Imperial College London, London, UK.

View Article and Find Full Text PDF
March 2005

Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice.

J Physiol 2004 Nov 26;560(Pt 3):867-81. Epub 2004 Aug 26.

Department of Biomedical Science, University of Sheffield, Alfred Danny Building, Western Bank, Sheffield S10 2TN, UK.

View Article and Find Full Text PDF
November 2004